Perhaps we should politely request the company not to make non compulsory announcements other than final results of trials, new license sales or distributor agreements.
It might save us the embarrassment of market reaction to company announcements.
- Forums
- ASX - By Stock
- SPL
- Ann: DEP irinotecan clinical data presented at AACR meeting
Ann: DEP irinotecan clinical data presented at AACR meeting, page-11
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.93M |
Open | High | Low | Value | Volume |
9.3¢ | 9.4¢ | 9.2¢ | $11.96K | 129.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 105945 | 9.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.9¢ | 1285 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 105945 | 0.092 |
2 | 161121 | 0.090 |
1 | 127200 | 0.087 |
1 | 6395 | 0.086 |
3 | 111000 | 0.085 |
Price($) | Vol. | No. |
---|---|---|
0.099 | 1285 | 1 |
0.100 | 114731 | 5 |
0.105 | 19523 | 2 |
0.110 | 16500 | 2 |
0.115 | 109827 | 3 |
Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |